We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App





Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event

By LabMedica International staff writers
Posted on 16 Dec 2020
Print article
Image: Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event (Photo courtesy of Roche)
Image: Roche Announces Newest Additions to Cobas Family of Analyzers at AACC 2020 Virtual Event (Photo courtesy of Roche)
Roche (Basel, Switzerland) showcased leading-edge technology at its virtual booth at 2020 AACC Annual Scientific Meeting with demonstrations of the company’s newest additions to the cobas family of analyzers.

At the AACC Virtual 2020 Annual Scientific Meeting & Clinical Lab Expo, Roche demonstrated its new cobas pro integrated solution that allows laboratories to experience a new improved level of simplicity while achieving mid to high volume clinical chemistry and immunochemistry testing needs. Visitors to Roche’s virtual booth at AACC 2020 were able to see firsthand the newest innovations, including reduced maintenance, cobas AutoCal, and long on-board reagent stability. The cobas pro integrated solution includes the cobas ISE analytical unit that measures the concentration of sodium (Na+), potassium (K+) and chloride (Cl-), the all-new cobas c 503 analytical unit for clinical chemistry, and cobas e 801 analytical unit for immunochemistry. The state-of-the-art cobas pro offers a range of advanced features that help optimize workflow, improve productivity, and enhance reliability and turnaround times to support patient care.

Roche also gave viewers a peek behind the curtain to the innovations offered by cobas pure integrated solutions, the newest member of the cobas family of systems that is designed to deliver excellence, while at the same time simplifying daily work. Built on the latest technology, cobas pure integrated solutions combines clinical chemistry, immunoassay and ISE1 diagnostic testing on a footprint of just two square meters to achieve low to mid volume testing needs.


New
Gold Supplier
HAI Assay Quality Control
Amplichek II
New
Glucose & Lactate Measuremen Device
ecobasic
New
Silver Supplier
CLIA Microwell Strip Luminometer
LumiStat 4900
New
Lactose Intolerance Test
Lactose Intolerance LCT Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: A new blood test could noninvasively and inexpensively detect colorectal cancer (Photo courtesy of Pexels)

Novel Blood Test Could Detect Early-Onset Colorectal Cancer

Colorectal cancer is the fourth most common cancer, according to the U.S. Centers for Disease Control and Prevention. The rate of colon or rectal cancers in people younger than 50 years old has been on... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.